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More than 6 billion people live outside industrialized countries and have insufﬁcient access to cardiac surgery.
Given the recently conﬁrmed high prevailing mortality for rheumatic heart disease in many of these countries
together with increasing numbers of patients needing interventions for lifestyle diseases due to an accelerating
epidemiological transition, a signiﬁcant need for cardiac surgery could be assumed. Yet, need estimates were
largely based on extrapolated screening studies while true service levels remained unknown. A multi-author
effort representing 16 high-, middle-, and low-income countries was undertaken to narrow the need
assessment for cardiac surgery including rheumatic and lifestyle cardiac diseases as well as congenital heart
disease on the basis of existing data deduction. Actual levels of cardiac surgery were determined in each of
these countries on the basis of questionnaires, national databases, or annual reports of national societies.
Need estimates range from 200 operations per million in low-income countries that are nonendemic for
rheumatic heart disease to >1,000 operations per million in high-income countries representing the end of
the epidemiological transition. Actually provided levels of cardiac surgery range from 0.5 per million in the
assessed low- and lower-middle income countries (average 107  113 per million; representing a
population of 1.6 billion) to 500 in the upper-middle-income countries (average 270  163 per million
representing a population of 1.9 billion). By combining need estimates with the assessment of de facto
provided levels of cardiac surgery, it emerged that a signiﬁcant degree of underdelivery of often lifesaving
open heart surgery does not only prevail in low-income countries but is also disturbingly high in middle-
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Hospital de Messejana,The evolution of cardiac surgery after the Second
World War was driven by 2 major objectives: to correct
congenital heart defects and to restore the function of heart
valves affected by rheumatic heart disease (RHD). As the
discipline became an integral part of medicine, the growing
afﬂuence in industrialized countries led to the near disap-
pearance of RHD and to the emergence of degenerative and
lifestyle diseases as primary indications for open heart
surgery. Further evolution in these high-income countries
(HIC) has witnessed the increasing importance of inter-
ventional cardiology and eventually an overcapacity in
cardiac surgery. The situation in the rest of the world,
however, has not followed this pattern and is currently
reminiscent of the earlier phases of this development.
Because rheumatic fever and RHD are still prevalent there,
low-income countries (LIC) often mirror the pre-cardiacGLOBAL HEART, VOL. 13, NO. 4, 2018
December 2018: 293-303surgery era of the 1950s, whereas middle-income coun-
tries (MIC) resemble the 1970s with large metropolitan
cardiac centers yet with an overall undercapacity of cardiac
surgery related to the needs of the population. Regrettably,
in spite of the fact that the World Health Organization
predicted heart diseases to become the number one cause
of death in LIC and MIC in the near future, access to
cardiac surgery in these countries remains grossly insufﬁ-
cient or, in some cases, lacking altogether.DATA COMPILATION
A multi-author survey was undertaken to address the
scarcity of knowledge regarding both cardiac surgical needs
and capabilities outside high-income regions. We have
used the annual reports of national societies or contacted293
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TABLE 1. Socioeconomic parameters of 16 countries (1 low income [Mozambique], 4 lower middle income [India, Nigeria, Morocco,
Tunisia], 8 upper middle income [Namibia, Algeria, Iran, South Africa, Cuba, China, Brazil, Russia], and 3 high income [Germany,
Singapore, United States]) opposite the number of cardiac surgical hospitals in total and broken down into public and private facilities
Population
in Millions
Gini
Index
GDP (USD)
Health Expenditure/yr
(USD)
Cardiac Centers
S in
Billions
Per
Capita
S in
Billions
Per
Capita
% of
GDP
S (Public/
Private)
Centers per Million Population/
Population per Center
S
Per Public
Patient
Population
Per Private
Patient
Population
Mozambique* 29 46 11 380 0.9 79 7 2 (1/1) <0.1/15 3*/0.3 0.03/29
India 1,330 35 2,260 1,710 106 267 5 517 (48/469) 0.4/2.2 NA NA
Nigeria 195 43 405 2,178 15 217 4 15 (9/6) 0.08/13 NA NA
Morocco 35 41 101 2,850 6 450 6 22 (7/15) 0.6/1.6 0.5/2.0 0.7/1.4
Tunisia 11 36 42 3,690 3 790 7 17 (5/12) 1.5/0.6 1.7/0.6 1.8/0.7
Namibia >2 61 10 4,140 <1 869 9 2 (1/1) 0.8/1.2 0.6/1.7 1.7/0.6
Algeriay 41 28 156 4,270 11 932 7 23 (8y/15) 0.6/1.7 0.6/1.7 0.8/1.2
Iran 80 39 404 5,050 28 1,080 7 105 (66/39) 1.3/0.7 1.2/0.8 1.6/0.6
South Africa 59 63 295 5,300 23 1,150 9 46 (8/38) 0.8/1.3 0.2/6.1 3.8/0.3
Cuba 11 41 87 7,602 10 2,475 11 6 (only public) 0.5/1.9 0.5/1.9 0
Chinaz 1,380 47 11,200 8,120 616 731 6 723 (718/5) 0.5/1.9 0.5/1.9 0.004/276
Brazilx 214 51 1,800 8,650 150 1,320 8 337x (337/320) 1.6/0.6 1.6/0.6 8.9/0.1
Russia 149 38 1,290 8,750 92 1,840 7 119 (only public) 0.8/1.3 0.8/1.3 0
Germanyz [16] 83 31 3,467 41,940 381 5,182 11 78 (all both) 0.9/1.1 1.0/1.0 9.4/0.1
Singapore 6 46 300 52,960 15 4,050 5 7 (3/4) 1.3/0.8 0.8/1.9 2.2/0.5
United States 323 41 18,600 57,470 3,200 >10,000 17
Each category was expressed as per million population having access to the respective service. S ¼ Total.
GDP, gross domestic product; NA, not applicable.
*Mozambique has 1 private center for its 300,000 private patients. As such, 3 per million although only 1 exists in the whole country.
yIn Algeria private patients have also access to public hospitals.
zIn China and Germany all patients have access to private facilities. In Germany, all institutions have both public and private patients.
xIn Brazil, only 5% of hospitals offering cardiac surgery are only public, all others treat public and private patients.
j gREVIEW
294the heads of leading cardiothoracic departments to obtain
national data on cardiothoracic surgery performed in the
relevant countries. Data obtained over a period of 12
months are shown in Tables 1 to 3 and Figures 1 to 4. The
authors are representatives of 13 LIC and MIC (including
the "BRICS" countries Brazil, Russia, India, China, and
South Africa) and 3 HIC. All authors participated in the
SoutheNorth Dialogue that led to the Cape Town Decla-
ration [1]. Several of the authors were also signatories of
the preceding Addis Ababa communique [2] and the Cairo
Accord [3].PATIENTS IN NEED
For cardiac surgery, the epidemiological transition that
accompanies a country’s transformation from low-to high-
income status means a gradual shift from young patients
with RHD to older patients with degenerative and lifestyle
diseases. Whereas the needs for heart surgery are well
deﬁned at the endpoint of this transition, they continue to
remain undeﬁned for the earlier part of this process.Patient needs in LIC
Although quantitatively ill deﬁned, it is evident that the
two groups of pathologies that still represent a majority of
patients in need of cardiac surgery in LIC are congenital
heart disease (CHD) and RHD [1-4].
Because the global burden of CHD is believed to be
relatively constant [5-9], it seems reasonable to estimate the
congenital cardiac surgical needs of LIC on the basis of both
global prevalence and local circumstances [9,10]. Screening
studies suggested a range of 2.2 to 14 cardiac defects per
1,000 live births [9,11-14]. In the United Kingdom, the
countrywide number of actually performed operations for
CHD in under-19-year-old patients was 4.5 per 1,000 live
births in 2015 [15].When all age groupswere included, there
were 8 operations per 1,000 live births both in the United
Kingdom [15] and in Germany [16]. Given the signiﬁcantly
lower levels of postnatal diagnosis in LIC and a rational re-
striction to the simple 70%of indications (atrial septal defects
[ASD]; ventricular septal defect [VSD]; tetralogy of Fallot
[TFO]; atrio-ventricular septal defect [AVSD]) under those
circumstances, 1 per 400 live births would be a conservativeGLOBAL HEART, VOL. 13, NO. 4, 2018
December 2018: 293-303
TABLE 2. Relationship between the number of annual cardiac operations and cardiac surgeons per million population expressed in total countrywide numbers and broken down into private
and public patients
% of Cardiac
Surgery Patients
With Access to
Private Sector
Open Heart Cases/yr Cardiac Surgeons
S (Public/Private)
S per
Million
Public
Operations
per Million
Public Patients
Private Operations
per Million
Private Patients S (Public/Private)
Pr ary
Adult rimary
Pe atric
Population/Surgeon
S (Public
Population per Public
Surgeon/Private
Population per
Private Surgeon)
Surgeon/Million
Population
S (Public Surgeon per
Public Population/Private
Surgeon per Private
Population)
Mozambique 1 122 (32/90) 7 1 306* 5 (4/1) 1 5,800 0.2 (0.1/3.4)
India 205,000 (mostly private) 154 NA NA 1,500 1,300 00 0.89 1.1
Nigeria 15y 100 (49/51) 0.5 0.3 1.8 11 (10/11) 3 18 0.06 (0.07/0.01)
Morocco 53 3,500 (1,400/2,100) 100 88 111 NA A NA NA
Tunisia 97 3,000 (800/2,200) 272 71 191 60 (20/40) 5 /8 0.18 (0.15/0.20) 5.5 (6.7/5.0)
Namibia 25 280 (150/130) 127 88 217 2 2 oth) 1.1 0.9 (0.9/0.9)
Algeria 66 7,300 (4,820/2,480) 178 161 187 96 (75/21) 8 12 0.23 2.3 (2.8/1.5)
Iran 30 42,000 (31,800/10,210) 525 568 425 242 (242/144) 21 /31 0.33 3.0
South Africa 17 8,400 (2,450/5,950) 142 50 595 103 (32/71) 9 13 0.57 (1.50/0.14) 1.7 (0.7/7.1)
Cuba NA 1,969 177 0 82 0.14 7.4
China 100 219,000 (212,000/7,000) 158 154 5 3,578 (3,533/45) 3,2 /350 0.39 2.6 (2.6/0.03)
Brazil 17 80,081 (66,541/13,540) 374 373 376 2,220 1,7 /495 0.1 (0.1/0.02) 10.4 (9.2/43.1)
Russia NA 71,300 481 481 0 1,196 1,0 /160 0.1 8.0 (8.0/0)
Germany [16] 12 103,128 (91,000/12,000) 1,243 1,247 1,200 958 0.09 11.5 (13/96)
Singapore 32 2,500 (1,700) 446 447 444 38 3 /5 0.15 (0.11/0.17) 6.6 (5.8/8.9)
Private operations were related to the population on private insurances or that can afford private medicine. Public operations were related to th population that depended on the public sector. Abbreviations as in
Table 1.
*Only 300,000 out of 29 million are deemed to be private patients in the country, receiving 90 operations per year. Three hundred and six is erefore, a purely theoretical extrapolation.
yRepresenting the population earning more than 70,000 USD and assumed to be ﬁnancially capable of affording private cardiac surgery.
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TABLE 3. Relative distribution of cardiac surgical cases between the 5 main categories (CABG; valves [in open heart surgery]; congenitals; other [including aortic surgery involving extracorporeal
circulation]; and TAVI)
% CABG % Valves (% RHD)
% RHD of All Ops
% Congenitals Other
TAVI/yr SPublic Sector Private Sector Public Sector Private Sector Public Sector Private Sector Public Sector Private Sector
Mozambique 0 5 50 (95) 26 (50) 25 19 57 31 12 0
India 25 49 57 (86) 19 (57) 24 13 21 5 11 160
Nigeria 0 17 0 14 7* 26 44 2 0 0
Morocco NA NA NA NA NA NA NA NA NA NA
Tunisia NA NA NA NA NA NA NA NA NA NA
Namibia 15 75 76 15 7 7 2 3 0
Algeria 20 60 60 30 31 15 18 5 2 529
Iran 52 21 (31) 7 8 2 17 120
South Africa 19 55 36 (55) 28 (12) 7 37 11 8 6 170
Cuba 26 24 22 28 0
China 9 18 28 (35) 23 (35) 9 35 42 28 15 900
Brazil 49 49 24 (60) 24 (60) 17 19 19 8 8 >1,000
Russia 50 0 17 (35) 0 6 23 0 10 700
Germany [16] 51 34 <1 6 9 >14,000
Singapore 52 59 25 (15) 21 (?) 9 4 14 16 90
Combined valve and coronary bypass procedures were counted as “valves.” Where available, the percentage of valve patients being operated for a rheumatic etiology were listed in brackets.
P
, total; CABG, coronary artery bypass graft; NA, not applicable; RHD, rheumatic heart disease; TAVI, transcatheter aortic valve implantation.
*Valves are not being operated on due to costs of prostheses.
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FIGURE 1. Number of open heart operations per million population per year related to the per capita gross domestic
product of each country. The upper half of the x-axis has been shortened 10:1 to accommodate 2 high-income
countries, Germany and Singapore.
gREVIEWjestimate of surgical needs for CHD in LIC. Related to 1
million population, the need for congenital cardiac surgery
would therefore be the crude birth rate divided by 0.4, as
opposed to 0.125 for the entire spectrum of CHD and all age
groups in HIC. As the crude birth rate varies between 43 for
the Chad and Burundi and 32 for Rwanda, between 80 and10.4
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FIGURE 2. World map highlighting the contributing count
million population are depicted for each country.
GLOBAL HEART, VOL. 13, NO. 4, 2018
December 2018: 293-303110 operations may be assumed to be needed for CHD per
million population at current birth rates in LIC.
The majority of cardiac surgical needs in adolescence
and adulthood in LIC, however, is due to RHD. The most
recent Global Burden of Disease study has estimated the
burden of RHD at 33 million [17-19], practically the same1.7
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ries. In the circles, the number of cardiac surgeons per
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FIGURE 3. Number of open heart operations per million population per year (y-axis) related to the Gini coefﬁcient of
each country (x-axis) as a means to describe the level of societal inequality. For each country, the level of cardiac
operations offered to public (blue) and private (green) patients was separately depicted.
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298as the worldwide human immunodeﬁciency virus infection
rate (World Health Organization Global Health Observa-
tory data 2017). The latest studies suggest that 4,440 per
million population suffer from nonsilent RHD in endemic
areas [17]. Due to the limited availability of cardiac surgery
in these regions, and therefore the lack of an endpoint of
referral in many endemic areas, few hard data are available
from which to extrapolate the proportion of patients with
RHD who will eventually need surgery. Several recent
studies have highlighted the need for surgery in symp-
tomatic patients, the majority of those presenting at tertiary
institutions. Sliwa et al. [20] showed that 22% of patients
reach this point within 30 months of becoming symp-
tomatic. Okello et al. [21] and Zhang et al. [22] reported
on the presentation of newly diagnosed RHD in Uganda. In
this cohort, 72% required valvular surgery at presentation
[21,22]. Cannon et al. [23] recently described a very
elegant multistate model that conﬁrmed the poor prognosis
for those aged 5 to 24 at the time of diagnosis, even in
Australia. Of those diagnosed as mild, almost 30% did
show progression over 10 years with 11% progressing to
severe disease, one-half of these needing surgery. Even
more concerning was the fact that 50% of those with severeRHD at the time of diagnosis required surgery within 2
years and 10% were dead within 6 years of diagnosis [23].
The REMEDY (Global Rheumatic Heart Disease Reg-
istry) study enrolled 3,343 patients from LIC and MIC in
Africa, India, and Yemen. Symptomatic patients with RHD
in need of cardiac surgery were typically young (median
age of 28 years), largely unemployed (75% of adults), and
often women of childbearing age [24]. With surgery
available in only a few of these countries (all upper-middle-
income countries), mortality was high, at 17% over the 2-
year follow-up with a median age of 29 years of those who
died [25]. Other studies reported mean mortalities at an
even younger age [26-28].
Estimates of RHD-related heart failure and death rates
in areas without surgery could serve as a conservative
means of assessing the need for cardiac surgery. With an
average age-standardized global RHD-related death rate of
48 per million population per year [17] (87 in endemic
areas) and a 3 times higher number of patients with signs
of signiﬁcant cardiac failure [17], a minimum of 150 op-
erations per million population per year may be conser-
vatively assumed. However, with variations of a factor of
3.5 in age-standardized mortality even within the endemicGLOBAL HEART, VOL. 13, NO. 4, 2018
December 2018: 293-303
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hot spots of the world [17], this number would be higher,
for example, for regions in Oceania (>300 per million),
Central Sub-Saharan Africa (>200 per million), or South
Asia (>200 per million).
If one attempts an overall assessment of cardiac sur-
gical needs in LIC, a sizable proportion of CHD cases must
be assumed to remain silent under the prevailing condi-
tions and, therefore, undiagnosed until they become
inoperable. This is in contrast to RHD, where adolescents
and young adults are likely to come forward once symp-
tomatic. As a result, an estimated 3 to 4 times more
patients with RHD than with CHD are likely to need car-
diac surgery in LIC. Therefore, one may conservatively
estimate the need for cardiac surgery in LIC to be 300 to
400 per million population within endemic hot spots such
as Oceania and 200 to 250 per million in the endemic
regions of South Asia and Sub-Saharan Africa.FIGURE 4. Epidemiologic transition reﬂected in the annual need for cardiac
surgery. Whereas the need for surgery for congenital heart disease (gray) is
largely constant throughout the world, rheumatic heart disease (blue) gets
gradually replaced by degenerative heart disease (green) as a country moves from
low-to high-income status over time. In Germany, for instance, this transition was
further advanced 60 years ago than in South Africa today. With all their unmet
need for cardiac surgery, a low-income developing country has a 4 times lower
overall requirement for cardiac surgery than a high-income country does with its
massive burden of degenerative heart disease.Patient needs in MIC
As the societies of MIC are at various stages in their tran-
sition to urbanization and industrialization, a variable
degree of overlap is seen between the cardiac surgical needs
of LIC, dominated by RHD, and of HIC with their pre-
dominance of degenerative and lifestyle diseases. If the
current situation of HIC predicts the endpoint of this
transition, the overall incidence of cardiac surgery of 1,300
per million population [16] in a country such as Germany
suggests a signiﬁcantly higher need for cardiac surgery for
degenerative and lifestyle diseases than the estimated 200
to 400 cardiac operations per million population even in
endemic areas of LIC. As such, the cardiac surgical needs of
MIC can be expected to increase slowly by a factor of 4 as
they go through the epidemiological and socioeconomic
transition from low- to high-income status. During this
transition, the two trends are concurrently unfolding in
opposite directions. Therefore, a decreasing relative prev-
alence of a rheumatic etiology of surgical valvular disease in
MIC may not only be a reﬂection of the disappearance of
RHD, but also a consequence of a concomitantly growing
absolute number of patients with degenerative valve dis-
ease. Underscoring this phenomenon, the 2015 share of
the worldwide burden of RHD was still 21% for upper MIC
such as China (23% of global RHD deaths) compared with
the 47% (43% of global RHD deaths) for lower MIC such
as India and Pakistan. Together, these 3 MIC composed
70% of worldwide cases [17], countering the perception
that RHD is restricted to Sub-Saharan Africa and has been
largely eradicated elsewhere.LACK OF CARDIAC SURGERY
Whereas access to cardiac surgery is largely absent in LIC,
it is available but often considerably restricted in many
MIC, resulting in >70% of the world population having
limited to no access to a service that would otherwise
prevent a massive number of deaths and suffering [26].GLOBAL HEART, VOL. 13, NO. 4, 2018
December 2018: 293-303In our comparison of 14 countries belonging to 4
income tiers, there was only a weak correlation between
the per capita gross domestic product and the provision of
cardiac surgery (Figure 1) even if related to health
expenditure (Table 1). Iran and South Africa, for instance,
spent nearly identical per-capita amounts on health
(Table 1), yet Iran performs 525 cardiac operations per
million as opposed to 142 in South Africa (Table 2).
Similarly, Nigeria’s per capita gross domestic product is
almost one-third higher than that of India, but India de-
livers 154 cardiac operations per million as opposed to
0.5 in Nigeria (Figure 1, Tables 1 and 2). Similarly, the
number of cardiac surgeons does not necessarily translate
into more cardiac operations. Both Brazil and Germany
have >10 cardiac surgeons per million population (10.4
per million vs. 11.5 per million) (Figure 2) as opposed to
3 per million in Iran. Yet, Germany provides >3 times
more cardiac operations per million population than
Brazil and Iran operates 1.5 times more patients with 3.5
times fewer surgeons. Except for the extreme end of the
spectrum, the Gini index as an expression of societal
inequality does not always correlate with access to cardiac
surgery: Algeria with a Gini index of 28 and South Africa
with 63 provide similar levels of cardiac surgery (127 per
million vs. 142 per million operations). Yet, an access
ratio between afﬂuent private patients and indigent pa-
tients of 12 in South Africa but only 1.2 in Algeria does
correlate with the extremely divergent Gini index between
these two countries (Table 1; Figure 3).299
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300Lack of cardiac surgery in LIC
In viewof the relativelyminimal impact prevention hasmade
in recent years [25], with the death rate not even halved over
the last one-quarter of a century [17], surgery will for a long
time remain an integral part of the treatment of RHD,
because cardiac surgery is eventually the only lifesaving
option for themajority of patients with symptomatic disease.
Yet, in most of the LIC, it is as good as absent. This lack of
access to cardiac surgery ismost glaring in Africa. The almost
1 billion people living in Sub-SaharanAfrica outside of South
Africa have access to only 22 cardiac centers [29]. According
to Yankah et al [29] there are 1,222 openheart operations per
million population in North America, and 18 per million in
Africa, which translates into 1 center per 120,000 people in
the United States and 1 center per 33 million people in Af-
rica. It is estimated that 10,000 cardiothoracic surgeons in
6,000 centers globally perform more than 2 million open
heart operations per year. Africa has 18 operations per
million people versus the global mean of 169 cases per
million [29,30].
Although it is widely understood today that local ca-
pacity building is the only way to address this problem,
humanitarian outreach programs often remain the only
source of at least sporadic provision of cardiac surgery.
These attempts to help have been criticized in many ways,
primarily for being the proverbial “drop in the ocean” at
great expense, though undoubtedly many lives have been
saved [31-33]. For example, Nigeria hosted their ﬁrst ﬂy-in
mission in 1974. Over the subsequent 3 decades, only 102
further patients underwent cardiac surgery, about one-half
of them children, some by visiting teams and some by local
surgeons [31,34]. Today’s cardiac surgical capacity of this
country of 195 million is still almost nonexistent with 0.5
operations per million (Table 2). Nongovernmental orga-
nizations have generally now shifted focus toward building
long-term partnerships with recipient sites with a vision to
eventually develop autonomous local services, because the
end goal must be to handle the indigenous pathologies
under the socioeconomic circumstances prevailing in the
affected countries. Following the same logic, regional
outreach missions from locally established cardiac centers
are better suited to the needs of underserved regions than
similar surgical missions that are based in HIC [26].
Similar to missions from HIC, local capacity building
also usually starts with an emphasis on children. A
continual high proportion of children being operated on
indicates that the overall needs exceed the existing capacity
resulting in prioritization of the most vulnerable. The
Aswan Heart Centre of the Chain of Hope, established in
2009 [26], is an example where >1,000 open heart pro-
cedures are now being performed per annum, of which
more than one-half are still children.Capacity gap of cardiac surgery in MIC
Although the ﬁrst open heart operations on cardiopulmo-
nary bypass were performed in Brazil in 1956, in China inX’ian in 1958 (by 1964, 20 hospitals were doing open heart
surgery), in South Africa by Christiaan Barnard in 1958,
and in Mumbai in 1961, population growth and epide-
miological transformations continue to outpace the rollout
of cardiac surgical capacity.
With an epidemiological transition that has as
endpoint a several-fold higher need for cardiac surgery
than existed at the starting point, the accuracy of the
overall need estimate of MIC for cardiac surgery depends
on the ability to determine the stage of both the epidemi-
ological and the socioeconomic transition. Two feedback
parameters appear particularly suited for this assessment:
the percentage of isolated coronary bypass graft operations
(CABG) reﬂecting the epidemiological transition (expected
to increase from low numbers [e.g., 9% in China] to more
than one-half of all procedures [Russia 50%, Brazil 53%,
Singapore 52%, and Germany 51%]), and the overall
number of cardiac operations performed per million pop-
ulation as a reﬂection of the socioeconomic transition (e.g.,
0.5 per million in Nigeria vs. 1,243 per million in Ger-
many). Mozambique, for instance, has a <5% CABG rate,
with 8 cardiac operations per million population (Table 1)
and as such clearly represents a very early phase of the
transition typical for a LIC. China’s national average of 9%
for CABG at 158 operations per million indicate a later but
still relatively early stage of both transitions. However,
national data may conceal the concurrence of parallel
societies within a country or societal differences between
countries. In China, for instance, the 27% CABG share at
big urban centers such as Fuwai highlights the urban-rural
gradient. In all MIC, cardiac surgery is often predominantly
located in metropolitan urban areas and their immediate
surroundings. Large centers such as Fuwai in Beijing with
15,000 open heart cases per year, Bakoulev in Moscow
with >5,000 per year or the All India Institute for Medical
Sciences in Delhi push up the national numbers, thereby
making undersupply in nonmetropolitan areas less
obvious. At the end of 2017, China had 723 cardiac centers
(0.5 per million population or 1.9 million population per
center) performing 219,000 open heart operations (158
per million population) (Tables 1 and 2). If equally
distributed, each center would have performed 303 cases
per year compared with 1,100 per center per year in
Germany. This situation is further aggravated by the fact
that 404 of the 723 hospitals (53%) performed <100
operations per year and 525 hospitals (79%) <300. As
such, 75% of all patients are largely operated in the 21%
urban hospitals performing >300 cases per year. It also
means that the 42% of the population living in rural areas
get only 25% of all cardiac operations often in units per-
forming <100 operations per year. Similar to China, most
of the centers performing open heart surgery in India are
located in the major cities and patients often have to travel
long distances for treatment. At the same time, whereas
there are 31 mostly metropolitan heart transplant centers
(in 2016 performing a total of 107 transplants), there are
still extremely underserviced rural regions. States such asGLOBAL HEART, VOL. 13, NO. 4, 2018
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Bihar, Mizoram, Sikkim, Manipur, Arunachal Pradesh,
Tripura, Nagaland, Meghalaya, Rajastan, Himachal Pra-
desh, and Uttarakhand, which account for one-quarter of
India with 15% of its population, have hardly any access to
cardiac surgery. Similarly, the densely populated, highly
urbanized South/South-East of Brazil has amassed a
disproportional share of the 337 cardiac centers of the
country. In Russia, before it was re-established as a separate
state in 1991, the leading heart centers in the country were
in Moscow, Kiev, Vilnius, Leningrad (now St. Petersburg),
Novosibirsk, and Gorkey (now Nizhniy Novgorod). Since
then, many new heart centers were opened throughout the
country adding up to a total of 119 in 2017. Yet, there is
still a distinct undersupply outside the metropolitan cen-
ters. Today, the least compromised situation is still in the
Central Federal district. Then comes the Pri Volga District
and Siberia. The worst conditions prevail in the North
Caucasus and the Far Eastern District.
In all MIC, 1 mitigating factor in this unequal access to
cardiac surgery lies in the lower cardiac surgical needs of
rural populations due to their slower epidemiological
transition evident from a prevailing bias of RHD over
lifestyle diseases. For instance, a 74% versus 57% rate of
urbanization and a 50% versus 9% CABG rate in Russia
and China, respectively, suggest that in relative terms, the 3
times lower per capita delivery of heart surgery in China
(154 per million population) compared with Russia (481
per million population) is not reﬂecting the full picture.
Yet, although less pronounced, the overall Chinese need
for cardiac surgery can still be expected to be lower than
that of Russia. Other reasons for hidden discrepancies may
be rooted in demographics. Whereas on the surface, Rus-
sia’s 50% CABG rate and 481 per million operations match
Singapore’s 52% CABG rate and 446 operations/million
(Table 2), the one (Russia’s) largely represents a post-
transition society with a high degree of degenerative and
lifestyle diseases with limited access to cardiac surgery, and
the other (Singapore’s) represent a younger population less
affected by degenerative diseases with full access to cardiac
surgery. Similarly, although Iran’s urbanization is high
(74%) as is its CABG rate (52%), a coexisting prevalence of
31% RHD in all valve patients suggests a mid-stage of
epidemiological transition. As such, the current level of
525 per million cardiac operations (the highest of all MIC)
may in relative terms cover an even higher proportion of
patients in need. At the end of the spectrum stand HIC
such as Germany with 51% CABG and 1,257 operations
per million [16], reﬂecting the patient needs of an aging,
afﬂuent, 76% urbanized population with full access to
cardiac surgery (Tables 1e3).
Whereas the epidemiological transition follows socio-
economic circumstances, the role of the private practice of
cardiac surgery crucially differs from country to country
not necessarily reﬂecting the Gini coefﬁcient of societal
inequality. At the extreme end is South Africa, where those
17% of the population who have access to private medicine
receive 595 cardiac operations per million, whereas theGLOBAL HEART, VOL. 13, NO. 4, 2018
December 2018: 293-30383% of the population who depend on public medicine
only receive 50 operations per million per year. Alterna-
tively expressed, 1 private hospital cares for 300,000 car-
diac surgical patients who have medical insurance (with
7.1 cardiac surgeons per million) as opposed to 6.1 million
patients per center who depend on the public sector (with
0.7 cardiac surgeons per million). In the Maghreb coun-
tries, in contrast, 72% of the population have access to
private medicine but because private facilities are reim-
bursed by procedure-related lump sum payments, the
more high-risk private patients are denied surgery and end
up receiving care on the public side. In this regard, the two
extremes are Russia and Cuba, where no private cardiac
surgery exists and Germany, where the entire population
has access to privately owned cardiac hospitals (but not to
the “private” services all hospitals including the publicly
owned ones offer). Thus, while private institutions and
surgeons are totally separate in South Africa, all cardiac
hospitals in Germany offer stepped up services to those
12% of the population who have a private top-up insur-
ance (baseline costs are covered by public insurances for
all). Legally similar (but increasingly showing signs of
ﬁnancial strain), the social service in Brazil provides every
citizen with free health care. The state insurance system
(Uniﬁed Health System) covers 83% of the population in
100% of hospitals. Similar to Germany, all cardiac hospi-
tals treat both private and public patients, except for the
5% of hospitals that are purely public. As such, private
patients who have either a private insurance (10%) or pay
out of pocket (7%) have access to 95% of cardiac centers.
In Iran, most doctors other than the professors (who are
full-timers at the University Hospitals) work both in public
and in private. A vast majority of all patients are treated
almost for free (10% in Social Security hospitals; 60% at
university hospitals, and 10% at hospitals belonging to
government organizations such as the military). The
remaining 20% are private patients treated in private
hospitals that were founded by doctors. In China, private
cardiovascular surgery has just begun to emerge. Theo-
retically, all of the 3,578 cardiovascular surgeons are
allowed to work at multiple places (e.g., public and pri-
vate). The government’s medical insurance largely covers
50% of the medical cost during any admission even in
private hospitals. In return, all government hospitals may
treat “private patients” who pay modestly more. The proﬁt
of the private hospitals is mainly from the medical
consumables because private hospitals can independently
negotiate the price of consumables. All together, there are
only 5 major private hospitals in China dedicated to
cardiovascular surgery operating on 3% of all patients. In
India, even in government hospitals, patients still need to
contribute 1,000 to 2,000 USD to a cardiac operation as
opposed to 3,000 to 5,000 USD in a private facility. Of all
cardiac hospitals, <10% are public. Government or state
employees get their main expenditure reimbursed if they
get operated on in a government-endorsed private hospital.
Some government schemes are in place allowing indigent301
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hospitals. Alternatively, private hospitals that were subsi-
dized by the state with free land have to provide a certain
percentage of service free to the poor. With the Narayana
Health Care facilities, a low-cost private system emerged
that entered collective insurance agreements for instance
with agricultural cooperatives. For literally pennies a
month, enrollees receive comprehensive coverage for all
surgeries.SUMMARY
HIC are past their epidemiological transition and have
developed well-established cardiac surgical services that
largely cover their population’s needs. As such, their
known prevalence of adult and pediatric cardiac operations
as well as their patterns of underlying pathologies can be
seen as a contemporary saturation point of an industrial-
ized society. LIC, in contrast, are largely in a pre-
epidemiological transition phase, and as such, needs are
very different from those of industrialized countries.
Although it is an acknowledged fact that the two main
pathologies requiring cardiac surgery in LIC are congenital
cardiac defects and RHD, estimates have been vague and
largely based on echocardiographic screening studies [35].
Recent global and regional epidemiological studies have,
for the ﬁrst time, correlated the prevalence of silent rheu-
matic valvular disease with that of cardiac failure and death
caused by the disease allowing conservative estimates of the
need for cardiac surgery for RHD. Although these indirect
deductions will remain estimates until such time when
well-established cardiac services provide ﬁrm data, they for
the ﬁrst time allow an approximate assessment of two core
questions: how many cardiac operations should one expect
to be needed in an LIC per million population and how
much do the needs for cardiac surgery differ between a pre-
transition LIC and a post-transition HIC. Conservatively
narrowing the range to 100 to 300 operations per million
population for LIC highlighted the fact that the gradual
disappearance of rheumatic heart RHD with afﬂuence and
its replacement with degenerative/lifestyle diseases will
translate into a 4 to 5 times higher need for cardiac surgery
once the epidemiological transition has been concluded
(Figure 4). This assumes today’s circumstances continue to
apply and does not take lifestyle changes and future pre-
ventive pharmacotherapies and other strategies into
account. An estimated ratio of 3 to 5:1 of RHD to CHD also
allows investigators to assign a rough numeric value to the
often less visible needs of rheumatic patients in LIC against
the background of children’s needs. Last but not least, MIC
have made impressive strides toward provision of cardiac
surgical services in the recent past. The simultaneous
presence of RHD and degenerative/lifestyle diseases in
these countries allows at least an informed guesstimate of
where the cardiac surgical needs of the population on the
epidemiological transition scale from 100 to 1,200 per
million may lie. Our multi-author attempt to deﬁne thenational status of open heart surgery in 1 LIC, 4 lower-
middle income countries, 8 upper-middle-income coun-
tries, and 2 HIC does not claim to accurately represent the
situation in all comparable countries. It does, however,
allow a very critical comparison of key parameters based on
major representatives in each group. In the short run it
may provide guidance for governments and nongovern-
mental organizations in LIC while also helping to predict
the medium-term to long-term developments in MIC. This
study was partially supported by the South African Na-
tional Research Foundation (NRF) through the grant for
rated scientists.
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